Jiangfeng Du (Yanfeng Gao)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 6

Top Topics

Molecular Dynamics Simulations

Top Venues

Chemical biology & drug design

Journal of chemical information and modeling

Investigational new drugs

Cell communication and signaling : CCS

This page only lists publications with an associated author ORCID identifier.

Publications

Yunshuo Zhao, Xiaotong Chen, Sifan Lyu, Zhe Ding, Yahong Wu, Yanfeng Gao, Jiangfeng Du
Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays. Chemical biology & drug design 98 (1) (2021)
Yunshuo Zhao, Xiaotong Chen, Zhe Ding, Chuanjie He, Guanfei Gao, Sifan Lyu, Yanfeng Gao, Jiangfeng Du
Identification of Novel CD39 Inhibitors Based on Virtual Screening and Enzymatic Assays. Journal of chemical information and modeling (2021)
Sifan Lyu, Yunshuo Zhao, Xiaobin Zeng, Xiaotong Chen, Qingqing Meng, Zhe Ding, Wenshan Zhao, Yuanming Qi, Yanfeng Gao, Jiangfeng Du
Identification of Phelligridin-Based Compounds as Novel Human CD73 Inhibitors. Journal of chemical information and modeling 61 (3) (2021)
Xiaotong Chen, Yunshuo Zhao, Sifan Lyu, Guanfei Gao, Yanfeng Gao, Yuanming Qi, Jiangfeng Du
Identification of novel inhibitors of GLUT1 by virtual screening and cell-based assays. Investigational new drugs 39 (5) (2021)
Pengli Zhang, Chengping Li, Xiaoyue Ji, Mingjie Gao, Sifan Lyu, Xiaojun Dai, Jiangfeng Du
In silico screening and surface plasma resonance-based verification of programmed death 1-targeted peptides. Chemical biology & drug design 95 (3) (2019)
Jiangfeng Du, Yaping Qin, Yahong Wu, Wenshan Zhao, Wenjie Zhai, Yuanming Qi, Chuchu Wang, Jiangfeng Du
The design of high affinity human PD-1 mutants by using molecular dynamics simulations (MD). Cell communication and signaling : CCS 16 (1) (2018)